About

Glenvas 4mg Capsule contains Lenvatinib as its active ingredient and belongs to a class of medications known as tyrosine kinase inhibitors. It is prescribed for the treatment of advanced or progressive thyroid cancer, particularly when radioactive iodine therapy is no longer effective. Additionally, it is used as a first-line treatment for patients with unresectable liver cancer (hepatocellular carcinoma) who are not candidates for surgery.

Anaplastic thyroid carcinoma, a severe form of thyroid cancer typically seen in patients over the age of 60, presents with symptoms such as a hard, enlarged thyroid gland and hoarseness, often due to vocal cord nerve involvement. Hepatocellular carcinoma, a common type of liver cancer, often arises from underlying liver conditions like cirrhosis or chronic hepatitis B.

Glenvas 4mg Capsule should not be taken by individuals who are allergic to Lenvatinib or any of its components. Patients are also advised to inform their dentist or oral surgeon before undergoing any dental procedures, as this medication may interfere with wound healing and increase the risk of bleeding.

Uses

Certain types of advanced thyroid cancer
Advanced Liver cancer
Certain types of kidney cancer
Endometrial cancer

Directions for use

This medicine will be administered by your doctor or nurse. Please do not attempt to self-administer it.

Side effects

Pain in joints or muscles
Hair loss
Sleeplessness
Protein in urine, frequent urination
Low potassium, magnesium, and calcium levels in the blood
Dehydration
Skin problems
Gall bladder inflammation
Increase in the values of cholesterol, thyroid-stimulating hormone, digestive enzymes
Delayed wound healing
Confusion
Difficulty speaking
Vision changes
Dizziness
Chest pain or pressure
Pain in arms, jaw, neck, and back
Breathing problems
Severe stomach pain
Blood clot formation
Blood in stools or coughing blood
Liver problems
Pain or soreness in the mouth, teeth, or jaw

Safety Measures

Alcohol - Avoid consuming alcohol during treatment with Glenvas 4mg Capsule, as it may increase the risk of side effects such as gastrointestinal bleeding or stomach ulcers.
Pregnancy - Glenvas 4mg Capsule is not safe during pregnancy, as it may cause harm to the developing fetus. It should be avoided by pregnant women or those planning to become pregnant.
Breastfeeding - Breastfeeding is not advised while taking Glenvas 4mg Capsule, as the medication may pass into breast milk and potentially harm the infant.
Liver - Since Glenvas 4mg Capsule is mainly processed by the liver, patients with liver conditions should inform their doctor before starting treatment. The medication can raise liver enzyme levels, indicating possible liver inflammation or damage. Regular liver function tests are recommended during therapy.
Kidney - Glenvas 4mg Capsule may affect kidney function, especially in patients with pre-existing kidney issues or those experiencing dehydration. Regular monitoring of kidney function is advised during treatment.

Disclaimer

Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location